Brian Wayda

Dr. Brian Wayda


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2023 in European Heart Journal
Verified
Journal Article
Open access
BWBrian Wayda
Brian Wayda
PAPhilipp Angleitner
Philipp Angleitner
JSJacqueline M Smits
Jacqueline M Smits
AKArne van Kins
Arne van Kins
MBMichael Berchtold-Herz
Michael Berchtold-Herz
AZAndreas Zuckermann
Andreas Zuckermann
Background and Aims: Given limited evidence and lack of consensus on donor acceptance for heart transplant (HT), selection practices vary widely across HT centres in the USA. Similar variation likely exists on a broader scale—across countries and HT systems—but remains largely unexplored. This study characterized differences in heart donor populations and selection practices between the USA and Eurotransplant—a consortium of eight European countries—and their implications for system-wide outcomes. Methods: Characteristics of adult reported heart donors and their utilization (the percentage of reported donors accepted for HT) were compared between Eurotransplant (n = 8714) and the USA (n = 60 882) from 2010 to 2020. Predictors of donor acceptance were identified using multivariable logistic regression. Additional analyses estimated the impact of achieving Eurotransplant-level utilization in the USA amongst donors of matched quality, using probability of acceptance as a marker of quality. Results: Eurotransplant reported donors were older with more cardiovascular risk factors but with higher utilization than in the USA (70% vs. 44%). Donor age, smoking history, and diabetes mellitus predicted non-acceptance in the USA and, by a lesser magnitude, in Eurotransplant; donor obesity and hypertension predicted non-acceptance in the USA only. Achieving Eurotransplant-level utilization amongst the top 30%–50% of donors (by quality) would produce an additional 506–930 US HTs annually. Conclusions: Eurotransplant countries exhibit more liberal donor heart acceptance practices than the USA. Adopting similar acceptance practices could help alleviate the scarcity of donor hearts and reduce waitlist morbidity in the USA.

5 September 2023 in Circulation
Verified
Journal Article
Closed access
KKKiran K. Khush
Kiran K. Khush
DMDarren Malinoski
Darren Malinoski
HLHelen Luikart
Helen Luikart
BWBrian Wayda
Brian Wayda
TGTahnee Groat
Tahnee Groat
JZJonathan Zaroff
Jonathan Zaroff
BACKGROUND: Left ventricular dysfunction in potential donors meeting brain death criteria often results in nonuse of donor hearts for transplantation, yet little is known about its incidence or pathophysiology. Resolving these unknowns was a primary aim of the DHS (Donor Heart Study), a multisite prospective cohort study. METHODS: The DHS enrolled potential donors by neurologic determination of death (n=4333) at 8 organ procurement organizations across the United States between February 2015 and May 2020. Data included medications administered, serial diagnostic tests, and transthoracic echocardiograms (TTEs) performed: (1) within 48 hours after brain death was formally diagnosed; and (2) 24±6 hours later if left ventricular (LV) dysfunction was initially present. LV dysfunction was defined as an LV ejection fraction 50% on the second TTE. TTEs were also examined for presence of LV regional wall motion abnormalities and their reversibility. We assessed associations between LV dysfunction, donor heart acceptance for transplantation, and recipient 1-year survival. RESULTS: An initial TTE was interpreted for 3794 of the 4333 potential donors by neurologic determination of death. A total of 493 (13%) of these TTEs showed LV dysfunction. Among those donors with an initial TTE, LV dysfunction was associated with younger age, underweight, and higher NT-proBNP (N-terminal pro-B-type natriuretic peptide) and troponin levels. A second TTE was performed within 24±6 hours for a subset of donors (n=224) with initial LV dysfunction; within this subset, 130 (58%) demonstrated reversibility. Sixty percent of donor hearts with normal LV function were accepted for transplant compared with 56% of hearts with reversible LV dysfunction and 24% of hearts with nonreversible LV dysfunction. Donor LV dysfunction, whether reversible or not, was not associated with recipient 1-year survival. CONCLUSIONS: LV dysfunction associated with brain death occurs in many potential heart donors and is sometimes reversible. These findings can inform decisions made during donor evaluation and help guide donor heart acceptance for transplantation.

30 November 2021 in American Journal of Transplantation
Verified
Journal Article
Open access
BWBrian Wayda
Brian Wayda
XCXingxing S. Cheng
Xingxing S. Cheng
JGJeremy D. Goldhaber-Fiebert
Jeremy D. Goldhaber-Fiebert
KKKiran K. Khush
Kiran K. Khush
Increasing rates of simultaneous heart-kidney (SHK) transplant in the United States exacerbate the overall shortage of deceased donor kidneys (DDK). Current allocation policy does not impose constraints on SHK eligibility, and how best to do so remains unknown. We apply a decision analytic model to evaluate options for heart transplant (HT) candidates with comorbid kidney dysfunction. We compare SHK with a “Safety Net” strategy, in which DDK transplant is performed six months after HT, only if native kidneys do not recover. We identify patient subsets for whom SHK using a DDK is efficient, considering the quality-adjusted life year (QALY) gains from DDKs instead allocated for kidney transplant-only. For an average-aged candidate with 50% probability of kidney recovery after HT-only, SHK produces 0.64 more QALYs than Safety Net at a cost of 0.58 more kidneys used. SHK is inefficient in this scenario, producing fewer QALYs per DDK used (1.1) than a DDK allocated for KT-only (2.2). SHK is preferred to Safety Net only for candidates with a lower probability of native kidney recovery (24 – 38%, varying by recipient age). This finding favors implementation of a Safety Net provision and should inform the establishment of objective criteria for SHK transplant eligibility.

1 October 2024 in Circulation: Heart Failure
Verified
Journal Article
Closed access
BWBrian Wayda
Brian Wayda
YWYingjie Weng
Yingjie Weng
SZShiqi Zhang
Shiqi Zhang
HLHelen Luikart
Helen Luikart
TPThomas Pearson
Thomas Pearson
KKKiran K. Khush
Kiran K. Khush
BACKGROUND: Despite a shortage of potential donors for heart transplant in the United States, most potential donor hearts are discarded. We evaluated predictors of donor heart acceptance in the United States and applied machine learning methods to improve prediction. METHODS: We included a nationwide (2005–2020) cohort of potential heart donors in the United States (n=73 948) from the Scientific Registry of Transplant Recipients and a more recent (2015–2020) rigorously phenotyped cohort of potential donors from DHS (Donor Heart Study; n=4130). We identified predictors of acceptance for heart transplant in both cohorts using multivariate logistic regression, incorporating time-interaction terms to characterize their varying effects over time. We fit models predicting acceptance for transplant in a 50% training subset of DHS using logistic regression, least absolute shrinkage and selection operator, and random forest algorithms and compared their performance in the remaining 50% (test) of the subset. RESULTS: Predictors of donor heart acceptance were similar in the nationwide and DHS cohorts. Among these, older age ( P value for time interaction, 0.0001) has become increasingly predictive of discard over time while other factors, including those related to drug use, infection, and mild cardiac diagnostic abnormalities, have become less influential ( P value for time interaction, <0.05 for all). A random forest model (area under the curve, 0.908; accuracy, 0.831) outperformed other prediction algorithms in the test subset and was used as the basis of a novel web-based prediction tool. CONCLUSIONS: Predictors of donor heart acceptance for transplantation have changed significantly over the last 2 decades, likely reflecting evolving evidence regarding their impact on posttransplant outcomes. Real-time prediction of donor heart acceptance, using our web-based tool, may improve efficiency during donor management and heart allocation.

13 September 2021 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
BWBrian Wayda
Brian Wayda
ASAlexander T. Sandhu
Alexander T. Sandhu
JPJustin Parizo
Justin Parizo
JTJeffrey J. Teuteberg
Jeffrey J. Teuteberg
KKKiran K. Khush
Kiran K. Khush

8 August 2024 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
EHErik J. Henricksen
Erik J. Henricksen
BWBrian Wayda
Brian Wayda
JTJeffrey J. Teuteberg
Jeffrey J. Teuteberg
HLHelen Luikart
Helen Luikart
JNJoyce Njoroge
Joyce Njoroge
KKKiran K. Khush
Kiran K. Khush